TABLE 1

Characteristics of 40 Patients with Suspected Metastatic Infectious Disease on Whom 18F-FDG PET Was Performed

CharacteristicTotal (n = 40)Metastatic foci
Yes (n = 30)No (n = 10)
Male (%)23 (58)17 (57)6 (60)
Female (%)17 (42)13 (43)4 (40)
Age (y)*60 ± 1760 ± 1760 ± 18
Community-acquired infection (%)30 (75)23 (77)7 (70)
Duration of symptoms until presentation (d)*1 ± 81 ± 71 ± 9
Duration of symptoms until adequate therapy (d)*2 ± 83 ± 82 ± 9
CVC present (%)13 (33)10 (33)3 (30)
Duration of CVC present (wk)*12 ± 6214 ± 691 ± 9
Total parenteral nutrition (%)9 (23)7 (23)2 (20)
Diabetes mellitus (%)4 (10)3 (10)1 (10)
Peritoneal dialysis (%)2 (5)1 (3)1 (10)
Hemodialysis (%)1 (3)01 (10)
Pacemaker (%)3 (8)3 (10)0
Congenital heart disease (%)3 (8)3 (10)0
Mechanical heart valve (%)2 (5)2 (7)0
Malignancy (%)1 (3)1 (3)0
Immunosuppressive drugs (%)8 (20)7 (23)1 (10)
Intravenous drug use000
Positive blood cultures (no. per patient)*3 ± 34 ± 32 ± 1
Duration of positive blood cultures (d)*2 ± 83 ± 81 ± 1
  • * Median ± SD.

  • One patient was excluded from these calculations because she had lower back pain, periodic low-grade fever, and fatigue for almost 3 y before she was diagnosed with a S. aureus psoas abscess and before 18F-FDG PET was performed.

  • P < 0.05.